Asons Pharmaceuticals Private Limited

Asons Pharmaceuticals Private Limited - pharma in Kalol, Gujarat, India. FY 2026 financials & compliance.
CIN U24304GJ2021PTC125300 Incorporated 02 September 2021 ROC Ahmedabad HQ Kalol, Gujarat, India
Active Private Limited Company pharma DPIIT Startup MSME · Small
Revenue · FY 2025
₹32.4 Cr
▲ 43% YoY
Net profit · FY 2025
₹8.35 Cr
Net margin 25.8%
EBITDA · FY 2025
₹13.37 Cr
EBITDA margin 41.3%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
₹107.17 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Employees · EPFO
10
Provident fund records

About Asons Pharmaceuticals Private Limited

Data last updated:

Asons Pharmaceuticals Private Limited is a private limited company based in Kalol, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 September 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24304GJ2021PTC125300. Its GSTIN is 24AAVCA7228A1ZR (Gujarat).

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Devangiben Jigneshkumar Shah and Jigneshkumar Ashvinbhai Shah.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at L.S No – 840/1 840/2 & 840/4, Village – Bedhiya Taluka – Kalol District – Panchmahal, Gujarat, India – 389310.

As per the financials filed for FY 2025, the company reported a revenue of ₹32.4 Cr, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹8.35 Cr (net margin 25.8%) and EBITDA of ₹13.37 Cr (EBITDA margin 41.3%). Revenue has grown at a compounded annual rate (CAGR) of 158% over three years.

The company has about 10 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹107.17 Cr on record. The company has 1 deal on record (1 rights issue); the latest was in November 2022. Its 6 peer companies in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Orichem Drugs & Pharmaceuticals Pvt. Ltd. with revenue of ₹33.03 Cr.

Asons Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0036694). For more details, the company can be reached via its website asonspharma.com.

Company details

CIN U24304GJ2021PTC125300
Registration Number 125300
Incorporation Date 02 September 2021
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-GJ-24-0036694

Recognitions & Rankings of Asons Pharmaceuticals

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-24-0036694

Contact details

Asons Pharmaceuticals Private Limited's registered office is in Kalol, Gujarat. Its website is asonspharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    L.S No – 840/1 840/2 & 840/4, Village – Bedhiya Taluka – Kalol District – Panchmahal, Gujarat, India – 389310
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Asons Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Asons Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Asons Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Asons Pharmaceuticals Private Limited, buy the company report.

Financials of Asons Pharmaceuticals Private Limited

FY 2025 filings available

Asons Pharmaceuticals Private Limited reported revenue of ₹32.4 Cr (up 43% YoY) for FY 2025.

Revenue · FY 2025
₹32.4 Cr ▲ 43%
Net profit · FY 2025
₹8.35 Cr margin 25.8%
EBITDA · FY 2025
₹13.37 Cr margin 41.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 158%
EBITDA CAGR growth
1 year
▲ 116%
3 years · compounded
▲ 238%

Revenue has grown at a compounded annual rate (CAGR) of 158% over three years, including 43% growth in the latest year. EBITDA rose 116% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹13.37 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹8.35 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin41.3%
Net Profit Margin25.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Asons Pharmaceuticals Private Limited, buy the company report.

Board of directors of Asons Pharmaceuticals Private Limited

Asons Pharmaceuticals has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Devangiben Jigneshkumar ShahDirector02 Sep 20215 Years 2 MonthsCurrent
Jigneshkumar Ashvinbhai ShahDirector02 Sep 20215 Years 2 MonthsCurrent
Kiran Mohanlal JainDirector20 Feb 20251 Years 9 MonthsCurrent
Uttamkumar Mohanlal JainDirector20 Feb 20251 Years 9 MonthsCurrent

Peer comparison

Asons Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Orichem Drugs & Pharmaceuticals Pvt. Ltd.₹33.03 Cr (FY 2025)21.0%Indore, Madhya Pradesh, India
Maheshwari Pharmaceuticals (India) Limited₹32.92 Cr (FY 2024)9.0%Delhi, India
Asolution Pharmaceuticals Private Limited₹32.73 Cr (FY 2024)11.0%Mumbai, Maharashtra, India
Asons Pharmaceuticals Private Limitedthis company₹32.4 Cr (FY 2025)₹8.35 Cr25.8%43.0%10Kalol, Gujarat, India
Torrvis Pharmaceuticals Private Limited₹31.91 Cr (FY 2025)12.0%Delhi, India
R P L (India) Pharmaceuticals Private Limited₹31.91 Cr (FY 2025)13.0%New Delhi, Delhi, India
Emcee Pharmaceuticals Pvt Ltd₹31.02 Cr (FY 2025)14.0%Kalyani, West Bengal, India

To see the full peer comparison of Asons Pharmaceuticals Private Limited, buy the company report.

Auditor

Asons Pharmaceuticals Private Limited is audited by AIMS & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
AIMS & ASSOCIATESFY 2023127628W

Shareholding

The shareholding of Asons Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Asons Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹107.17 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹107.17 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Jun 2025101116628Others₹19 CrOpen
27 Jun 2025101117705Others₹49.75 CrOpen
15 Mar 2022100551183Others₹17.29 CrOpen
31 Dec 2021100551173Others₹21.13 CrOpen

To see the full charge records of Asons Pharmaceuticals Private Limited, buy the company report.

Total charge records: 4 View all charges

Deals & funding

Asons Pharmaceuticals Private Limited has 1 deal on record (1 rights issue); the latest was in November 2022.

Total deals
1
Rights issue
1

Deals on record (1 of 1)

WhenDealAmountParties
Nov 2022Rights issue₹2.99 CrInvestors: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Asons Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Asons Pharmaceuticals Private Limited has a workforce of 10 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
10
Active EPFO establishments
1
Employee growth
-63%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2710
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22

To see the full employee and EPFO history of Asons Pharmaceuticals Private Limited, buy the company report.

GST

Asons Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAVCA7228A1ZRGujaratActive16 Sep 2021

To see the full GST registrations and return filing status of Asons Pharmaceuticals Private Limited, buy the company report.

Recent activity

Asons Pharmaceuticals Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Kiran Mohanlal Jain was appointed as Director on 20 Feb 2025.

AGM
Asons Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 19.00 Cr with Charge ID 101116628 was registered on 27 Jun 2025.
Charges
A charge with Others amounted to Rs. 49.75 Cr with Charge ID 101117705 was registered on 27 Jun 2025.
Charges
A charge with Others of Rs. 17.29 Cr registered on 15 Mar 2022 with Charge ID 100551183 was modified on 15 May 2025.
Filing
Asons Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others of Rs. 21.13 Cr registered on 31 Dec 2021 with Charge ID 100551173 was modified on 29 Mar 2025.
Appointed
Kiran Mohanlal Jain was appointed as Director.
Appointed
Uttamkumar Mohanlal Jain was appointed as Director.
Charges
A charge with Others amounted to Rs. 17.29 Cr with Charge ID 100551183 was registered on 15 Mar 2022.
Charges
A charge with Others amounted to Rs. 21.13 Cr with Charge ID 100551173 was registered on 31 Dec 2021.
Appointed
Devangiben Jigneshkumar Shah was appointed as Director.
Appointed
Jigneshkumar Ashvinbhai Shah was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Asons Pharmaceuticals is an active private limited company based in Kalol, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 September 2021 (5+ years old) and is registered under CIN U24304GJ2021PTC125300.

Asons Pharmaceuticals has 4 current directors:

The latest financial statements of Asons Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Asons Pharmaceuticals is 24AAVCA7228A1ZR, registered in Gujarat.

The CIN (Corporate Identification Number) of Asons Pharmaceuticals is U24304GJ2021PTC125300. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Asons Pharmaceuticals was incorporated on 02 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Asons Pharmaceuticals has 1 deal on record (1 rights issue); the latest was in November 2022.

The peers of Asons Pharmaceuticals by revenue are Orichem Drugs & Pharmaceuticals Pvt. Ltd, Maheshwari Pharmaceuticals (India) Limited, Asolution Pharmaceuticals Private Limited, Torrvis Pharmaceuticals Private Limited, R P L (India) Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Kiran Mohanlal Jain was appointed as Director on 20 Feb 2025. Uttamkumar Mohanlal Jain was appointed as Director on 20 Feb 2025. Devangiben Jigneshkumar Shah was appointed as Director on 02 Sep 2021. Asons Pharmaceuticals has 4 board changes on record in total.

Yes, Asons Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Asons Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-24-0036694).